Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (23)
COVID-19 (6)
Type
(
1 selected
)
Type
Guidance (1861)
NICE advice (323)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (223)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (601)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (339)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (761)
Apply filters
Showing 211 to 220 of 1861
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Blood transfusion
NG24
18 November 2015
18 November 2015
Bone-anchored cystourethropexy
IPG18
26 November 2003
26 November 2003
Borderline personality disorder: recognition and management
CG78
28 January 2009
28 January 2009
Bortezomib and thalidomide for the first‑line treatment of multiple myeloma
TA228
27 July 2011
27 July 2011
Bortezomib for induction therapy in multiple myeloma before high-dose chemotherapy and autologous stem cell transplantation
TA311
23 April 2014
23 April 2014
Bortezomib for previously untreated mantle cell lymphoma
TA370
16 December 2015
16 December 2015
Bortezomib for treating multiple myeloma after second or subsequent relapse (terminated appraisal)
TA453
5 July 2017
5 July 2017
Bortezomib monotherapy for relapsed multiple myeloma
TA129
23 October 2007
23 October 2007
Bosutinib for previously treated chronic myeloid leukaemia
TA401
24 August 2016
24 August 2016
Bosutinib for untreated chronic myeloid leukaemia (terminated appraisal)
TA576
17 April 2019
17 April 2019
Previous page
1
…
20
21
Current page
22
23
24
…
187
Page
22
of
187
Next page
Results per page
10
25
50
All
Back to top